Open AccessSuccessful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
Author(s) -
Hashimoto Akiko,
Tanaka Yasuhiro,
Shinzato Isaku
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4300
Subject(s) - arsenic trioxide , acute promyelocytic leukemia , medicine , hemodialysis , arsenic , adverse effect , leukemia , gastroenterology , retinoic acid , biochemistry , materials science , chemistry , metallurgy , gene
A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.